About this trial
This study innovatively utilizes multi-modal hemodynamic monitoring (Norepinephrine equivalence, NEE+Pulse indicator Continuous Cariac output, PiCCO) to investigate the optimal timing of initiation of oXiris in abdominal infection-associated septic shock patients and to investigate prognosis on sepsis phenotypes undergoing oXiris therapy.
Eligibility criteria
Qualifiers
Age ≥18 years;
Weight ≥30 kg;
Intra-abdominal infection (blood or abdominal drainage fluid culture positive for Gram-negative bacteria or suspected to be caused by a Gram-negative agent);
Diagnostic septic shock (Sepsis 3.0): Sepsis was defined as "life-threatening organ dysfunction caused by a dysregulated host response to infection" with organ dysfunction defined as an increase in qSOFA ⩾2 points. Septic shock was defined as sepsis requiring vasoactive therapy to maintain mean arterial pressure (MAP) ⩾ 65 mmHg and lactate elevation to >2 mmol/L despite adequate volume resuscitation;
Disqualifiers
Patients with highly contagious infectious diseases, such as tuberculosis;
Pregnant and lying-in woman or lactation period;
Infection of other sites (no abdominal infection like pneumonia, central nervous system infection and so on);
CRRT cannot be performed for various reasons;
Trial design
Treatments tested in this trial
- CRRT filter